Related Experiment Video

Updated: Jun 30, 2025

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K

Next Generation Weight Loss Drugs for the Prevention of Cancer?

Chantelle Carbonell1, Mariet Mathew Stephen1, Yibing Ruan1,2

  • 1Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Cancer Control : Journal of the Moffitt Cancer Center
|March 22, 2024
PubMed

Insights

Next-generation weight loss drugs, like GLP-1 receptor agonists, could prevent over 71,000 cancers in Canada by 2049. While not a perfect solution, these medications offer a new tool for obesity and cancer prevention.

Area of Science:

  • Public Health
  • Pharmacology
  • Oncology

Background:

  • Obesity is a significant risk factor for cancer in Western populations.
  • Pharmacological interventions, including GLP-1 receptor agonists (GLP-1RA), are being explored for weight management.
  • Rising obesity rates correlate with an increasing burden of obesity-related cancers.

Purpose of the Study:

  • To assess the potential of next-generation weight loss drugs (NGWLD) for population-level cancer chemoprevention.
  • To estimate the impact of NGWLD on obesity and obesity-related cancer rates in Canada.

Main Methods:

  • Utilized the OncoSim microsimulation tool for population-level analysis.
  • Projected obesity and cancer incidence over a 25-year period (by 2049).
  • Modeled the potential impact of NGWLD interventions.

Main Results:

  • Estimated 71,281 preventable cancers in Canada by 2049.
  • Projected 36,235 and 35,046 cancers preventable in females and males, respectively.
  • Approximately 1.3% of all projected cancer cases (327,254) in 2049 could be prevented by NGWLD.

Conclusions:

  • Pharmacological intervention is an additional tool, not the sole solution, for the obesity-cancer crisis.
  • NGWLD can aid in rapid body weight and adiposity reduction in challenging populations.
  • Further research is crucial for preventing initial weight gain and ensuring long-term weight maintenance.
Keywords:
Glucagon-like peptide-1 receptor agonistscancer preventionchemopreventionpharmacologyweight loss

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

7.2K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.7K

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K